Although mental disorders have multifactorial causes, genetics can explain some of them, yet this field remains largely unexplored in terms of guiding diagnoses and treatments. In the largest study of its kind ever conducted and\u00a0published\u00a0in the journal\u00a0Nature, an international consortium of researchers compared common genetic variants in 14 psychiatric conditions and classified them into five major groups. These groups, referred to in the study as factors, share genetic variants with each other.<\/p>\n
<\/p>\n
Psychiatric disorders have symptoms in common, which makes diagnosis difficult, as it’s still based solely on clinical evaluation. This work shows, from a genetic point of view, what clinicians have already observed in relation to schizophrenia and bipolar disorder, for example, which co-occur and which, biologically, may represent a continuum, with 80% of the genetic variants shared between the two conditions.”\u00a0<\/p>\n
\n <\/p>\nDiego Luiz Rovaris, Professor, University of S\u00e3o Paulo’s Biomedical Sciences Institute (ICB-USP), Brazil<\/p>\n
\n<\/p><\/blockquote>\n
Rovaris is\u00a0supported by FAPESP\u00a0and is participating in the study<\/p>\n
Factor 1 includes compulsive disorders such as anorexia nervosa and obsessive-compulsive disorder (OCD), as well as Tourette syndrome and anxiety disorders, which are related but to a lesser extent. Factor 2 is defined by schizophrenia and bipolar disorder, which share, among other characteristics, gene expression in excitatory neurons and in regions of the brain involved in processing reality.<\/p>\n
Factor 3, which is linked to neurodevelopment, includes autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and Tourette syndrome to a moderate extent. This factor is largely explained by genes that express themselves very early in brain development. In 2023, Rovaris was part of the group that published the discovery of 76 ADHD-related genes in\u00a0Nature Genetics.<\/p>\n
Factor 4 includes internalizing conditions such as depression, anxiety disorders, and post-traumatic stress disorder (PTSD). The most highly expressed genes in this group are linked not to neurons but to glia, which are support cells. This suggests that depression and anxiety are more closely linked to brain infrastructure maintenance than to neurons that transmit signals.<\/p>\n
Finally, factor 5 is related to substance abuse, including alcohol use disorder, nicotine dependence, cannabis use disorder, and opioid use disorder. In this factor, variants were found in genes encoding the enzyme that breaks down alcohol and the receptors that respond to nicotine.<\/p>\n
This factor was most closely associated with socioeconomic indicators, such as income and cognitive ability. This suggests that it may be more closely linked to environmental factors than the other factors analyzed.<\/p>\n
“Our genome has rare and common genetic variants. This study looked only at the common ones, more specifically single nucleotide polymorphisms [SNPs]. This is a category of variants with a major impact on multifactorial diseases, such as psychiatric conditions,” explains\u00a0Sintia Belangero, a professor at the S\u00e3o Paulo School of Medicine at the Federal University of S\u00e3o Paulo (EPM-UNIFESP), who also participated in the study and is\u00a0supported by FAPESP.<\/p>\n
In 2022, Belangero was part of the group that published the discovery of more than 100 genes related to schizophrenia in\u00a0Nature\u00a0(read more at\u00a0agencia.fapesp.br\/38467).\u00a0<\/p>\n
Of all the analyzed conditions, Tourette syndrome shares the fewest genetic characteristics with other disorders. Eighty-seven percent of these characteristics are unique to the condition. Researchers also found the so-called P factor, a set of genetic variants related to all 14 conditions analyzed. The study compared more than one million diagnosed cases with each other and with people without psychiatric conditions.<\/p>\n
The results may help in the search for new treatments, including through drug repurposing. In this approach, a drug approved for one condition is applied to another, which already occurs for some psychiatric diseases.<\/p>\n
Data cross-referencing<\/p>\n
Belangero and Rovaris point out that the analyses were restricted to populations of European origin due to the disproportionate amount of data from these populations in this type of study. However, they say this is changing as groups in Brazil work to provide data on the Brazilian population through the Latin American Genomics Consortium (LAGC) and increase Latin America’s representation in such studies.<\/p>\n
This initiative is affiliated with the Psychiatric Genomics Consortium (PGC), which collects genomic data related to psychiatric conditions in populations around the world.<\/p>\n
The method used, known as a genome-wide association study (GWAS), robustly reinforced what other genetic evidence and clinical data had already suggested, allowing for further studies on psychiatric conditions.<\/p>\n
In a\u00a0previous study, Rovaris, Belangero, and other authors concluded that 85% of participants in psychiatric genetics research have European ancestry.<\/p>\n
Neurodiversity<\/p>\n
According to an estimate published in 2005, half of the world’s population will meet the criteria for at least one mental disorder during their lifetime.<\/p>\n
In a\u00a0commentary\u00a0in the same issue of\u00a0Nature\u00a0that published the study, Abdel Abdellaoui, a professor at the University of Amsterdam in the Netherlands, notes that much of the genetic variation associated with clinical disorders overlaps with normal traits such as cognition, sleep, personality, and social behavior. He also notes that not all associations are negative.<\/p>\n
“Psychiatric disorders seem to arise more frequently at the extremes of this genetic variation continuum, when certain gene and life experience combinations overlap unfavorably. This should reposition mental illness not as part of defective biology but as the intersection of natural variation and environmental stress,” he writes.<\/p>\n
Among the study’s authors is\u00a0Euripedes Constantino Miguel, a professor at the USP Medical School and coordinator of the\u00a0Center for Research and Innovation in Mental Health\u00a0(CISM), an Applied Research Center (ARC) of FAPESP.<\/p>\n
Also participating from EPM-UNIFESP were\u00a0Vanessa Ota,\u00a0Ary Gadelha,\u00a0Rodrigo Bressan,\u00a0Marcos Santoro, Cristiano Noto,\u00a0Carolina Carvalho, and\u00a0Pedro Mario Pan. The other Brazilian authors involved are from the Hospital de Cl\u00ednicas in Porto Alegre and the Federal University of Rio Grande do Sul (UFRGS).<\/p>\n
Source:<\/p>\n
S\u00e3o Paulo Research Foundation (FAPESP)<\/a><\/p>\n
Journal reference:<\/p>\n